Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The erection pill]

A A Lycklama à Nijeholt1

  • 1Leids Universitair Medisch Centrum, afd. Urologie, Leiden.

Nederlands Tijdschrift Voor Geneeskunde
|December 29, 1998
PubMed
Summary
This summary is machine-generated.

Sildenafil (Viagra) is a new treatment for erection disorders, openly discussed now. Safety in the elderly is a concern, but it

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].

Nederlands tijdschrift voor geneeskunde·2001
Same author

Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention.

Urology·2000
Same author

[Benign prostate hyperplasia; shared care reduces care load].

Nederlands tijdschrift voor geneeskunde·1999
Same author

Effects of the bisphosphonate olpadronate in patients with carcinoma of the prostate metastatic to the skeleton.

Bone·1998
Same author

Trazodone, a double blind trial for treatment of erectile dysfunction.

International journal of impotence research·1997
Same author

[Epididymitis or testis malignancy?].

Nederlands tijdschrift voor geneeskunde·1996
Same journal

[Insulin intoxications caused by falsified semaglutide].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Professional skepticism in medical research].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Improving mobility in painful osteoarthritis].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The effectiveness and costs of the Back At work After Surgery (BAAS) work-integrated care pathway on return to work for patients receiving knee arthroplasty].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The rise of genetic therapies: urgent moral and societal questions].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[A man with a wound on his elbow].

Nederlands tijdschrift voor geneeskunde·2026
See all related articles

Area of Science:

  • Urology
  • Pharmacology
  • Men's Health

Background:

  • Erection disorder prevalence is higher than expected, affecting 10% of men aged 40-70 in the USA and Netherlands.
  • Embarrassment and lack of simple treatments contributed to underreporting of erection disorders.
  • The introduction of sildenafil has prompted open discussion about erection problems.

Purpose of the Study:

  • To assess the impact and implications of sildenafil's introduction for treating erection disorders.
  • To understand patient attitudes towards sildenafil and other treatment options.
  • To highlight safety considerations for sildenafil use, particularly in elderly populations.

Main Methods:

  • Review of international attention and prevalence data for erection disorders.

Related Experiment Videos

  • Analysis of an interview investigation in Leiden, Netherlands, involving 200 men with erection problems.
  • Consideration of age as a risk factor and contraindications for sildenafil use.

    • Main Results:

    • Two-thirds of men with erection problems had previously consulted a physician.
    • One-third of participants were interested in an erection pill, one-third in other treatments, and one-third in any treatment.
    • Age is a primary factor in erection disorder, raising safety concerns for elderly users.

    Conclusions:

    • Sildenafil represents a significant advancement in treating erection disorders.
    • Most men with erection problems are serious about seeking treatment.
    • Sildenafil is likely to become a preferred treatment, with contraindications including nitrate use and poor cardiovascular condition.